| PERIOD ENDING | 25-Sep-09 | 25-Jun-09 | 25-Mar-09 | 25-Dec-08 | | Total Revenue | 6,290 | 5,630 | 3,963 | 8,184 | | Cost of Revenue | 6,560 | 6,513 | 5,518 | 8,023 | | | Gross Profit | (270) | (883) | (1,555) | 161 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 643 | 590 | 1,385 | 2,379 | | Non Recurring |
-
|
-
|
-
| 4,925 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (913) | (1,473) | (2,940) | (7,143) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (519) | 2 | 96 | 140 | | Earnings Before Interest And Taxes | (1,432) | (1,471) | (2,844) | (7,003) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,432) | (1,471) | (2,844) | (7,003) | | Income Tax Expense | 1 |
-
| (349) | (51) | | Minority Interest |
-
| 1 | 1 | 190 | | | | Net Income From Continuing Ops | (1,433) | (1,470) | (2,494) | (6,762) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,433) | (1,470) | (2,494) | (6,762) | | Preferred Stock And Other Adjustments | (238) | (274) | (320) | (368) | | | Net Income Applicable To Common Shares | ($1,671) | ($1,744) | ($2,814) | ($7,130) |
|
0.49% Nasdaq 0.00%
Income Statement
